Benzinga | Jun 30, 2021 10:08AM EDT

Accelerate Diagnostics Says Will Have 3 Data Presentations At European Congress Of Clinical Microbiology & Infectious Diseases

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that it will have 3 data presentations from its Improving Outcomes and Antibiotic Stewardship (IOAS) Study at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) to be held July 9--12, 2021. The purpose of this landmark study is to compare data before and after implementation of the Accelerate Pheno system across several hospitals to determine the effects of the system on treating patients with bloodstream infections.

The ePoster presentations are from real-world clinical use of the Accelerate Pheno system in diverse health systems and include endpoints for microbiology test turnaround time, antimicrobial use, and a subgroup analysis that measured 30-day mortality. The data further highlight the clinical benefits of using the Accelerate Pheno system, with significant improvements in multiple endpoints, including a statistically significant reduction in 30-day mortality in the Accelerate Pheno arm (AXDX) versus standard of care testing arm (SOC) in a subset of patients on ineffective empirical antibiotic treatment (6.0% in AXDX vs. 15.9% in SOC).

The Company's presentations, which are available now on the ECCMID 2021 website, include:

Antimicrobial Use in Patients with Bloodstream Infections from 4 Hospitals in the IOAS Study: A Quasi-Experimental Multicenter Study of the Accelerate PhenoTest(r) BC Kit

Cedars-Sinai, University of Arkansas, Allegheny Health, University of Iowa

Abstract Number: 661

ePoster Session: S147-3c

Evaluating the Impact of the Accelerate PhenoTest(r) BC Kit (AXDX) on Patients with Bloodstream Infections Receiving Ineffective Empirical Antibiotic Treatment: IOAS Study Experience of 4 Hospitals

Cedars-Sinai, University of Arkansas, Allegheny Health, University of Iowa

Abstract Number: 664

ePoster Session: S138-2b

Impact of the Accelerate PhenoTest(r) BC Kit on Time to Results for Pathogens from Bloodstream Infections: IOAS (Improving Outcomes and Antibiotic Stewardship) Study Experience of 4 Hospitals

Cedars-Sinai, University of Arkansas, Allegheny Health, University of Iowa

Abstract Number: 758

ePoster Session: S147-3c

To view the presentations or more information, visit the ECCMID 2021 website at: https://www.eccmid.org/.